Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib and Olaparib in Ovarian Cancer (e-Volve)
NCT02340611Phase 2Completed
- Sponsor
- University Health Network
- Start
- Jun 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cediranib in ovarian cancer, sponsored by University Health Network. Started Jun 2015; status: completed.
02
Drugs
cediranib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT02340611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02340611.